Table 3.
Regression analysis of cytokines in vitD group compared to placebo group
| Unadjusted | Adjusted | |||
|---|---|---|---|---|
| Cytokine | β (95 % CI) | p-value | β (95 % CI) | p-value |
| Anti-iCD3/iCD28 | ||||
| IL-2 | −0.10 (−0.77, 0.56) | 0.76 | −0.26 (−0.93, 0.42) | 0.44 |
| IL-6 | 0.17 (−0.13, 0.47) | 0.27 | 0.23 (−0.09, 0.54) | 0.16 |
| IL-10 | 0.33 (0.02, 0.65) | 0.03 | 0.62 (0.44, 0.80) | <0.000 |
| TNF-α | 0.41 (0.002, 0.81) | 0.04 | 0.38 (−0.00, 0.84) | 0.05 |
| IFN-γ | 0.40 (−0.14, 0.93) | 0.14 | 0.42 (−0.17, 0.95) | 0.17 |
| IL-17A | 0.23 (−0.06, 0.52) | 0.12 | 0.24 (−0.08, 0.56) | 0.15 |
| PHA | ||||
| IL-2 | −0.42 (−1.13, 0.29) | 0.24 | −0.30 (−0.96, 0.36) | 0.36 |
| IL-6 | 0.17 (−0.13, 0.47) | 0.27 | 0.19 (−0.11, 0.48) | 0.21 |
| IL-10 | 0.16 (−0.27, 0.58) | 0.46 | 0.21 (−0.19, 0.62) | 0.29 |
| TNF-α | 0.20 (−0.25, 0.65) | 0.38 | 0.25 (−0.18, 0.67) | 0.25 |
| IFN-γ | 0.53 (−0.09, 1.15) | 0.09 | 0.59 (−0.006, 1.17) | 0.05 |
| IL-17A | 0.15 (−0.51, 0.81) | 0.65 | 0.21 (−0.45, 0.87) | 0.53 |
Data were given as beta (β) and 95 % confidence interval; β, regression coefficients. Adjusted for Delivery mode, gestational week and baseline 25(OH)D3 level